Non-invasive Diagnostic of Helicobacter pylori in Stools by Nested-qPCR by Taborda, María I. et al.
Polish Journal of Microbiology
2018,  Vol. 67,  No 1,  11–18
ORIGINAL PAPER
* Corresponding author: G. Bernal, Laboratory of Molecular and Cellular Biology of Cancer, Department of Biomedical Sciences, 
Faculty of Medicine, Universidad Católica del Norte, Coquimbo, Chile; e-mail: gbernal@ucn.cl
Introduction
Helicobacter pylori is responsible for gastritis and 
peptic ulcers; moreover, it is one of the most studied 
causal agents of gastric cancer (GC) in the last years 
(Misra et al., 2014), for which in 1994 it was considered 
as group I carcinogen by the International Agency for 
Research on Cancer (IARC, 2012). Infection is frequent 
during childhood and sometimes induces superficial 
gastritis, which can progress to atrophic gastritis, intes-
tinal metaplasia, dysplasia, and finally GC (Philippe 
et al., 2016). The gram-negative bacterium adheres and 
colonizes the gastric mucosa, with the participation of 
several virulence factors, including cytotoxin-asso-
ciated gene A antigen (CagA) and vacuolating cytotoxin 
(VacA), as well as: induced by contact with epithelium 
(IceA), blood group antigen-binding adhesion (BabA), 
sialic acid-binding adhesion (SabA), duodenal ulcer-
promoting gene (DupA), and outer inflammatory pro-
tein (OipA) (Cadamuro, 2014). 
In South America, and particularly in Chile, more 
than 70% of population is positive for H. pylori (Coelho 
and Coelho, 2014), a rate that has been significantly 
stable during the last 10 years. Different studies have 
shown a prevalence of infection ranging from 60% to 
79%, according to socio-economic, educational and 
health conditions of the population studied (Ministe-
rio de Salud, 2013). Chile has one of the highest rates of 
H. pylori infection in the world (Ferreccio et al., 2007; 
Porras et al., 2014), making it necessary to develop 
a fast, reliable and non-invasive method to detect the 
pathogen, before the infected patient develops any gas-
tric pathology, including cancer. 
Currently there are two basic genres of tests to 
detect infection by H. pylori: invasive and non-invasive. 
Invasive tests including culture, histology and the rapid 
urease test (RUT) (Hunt et al., 2011; Lee et al., 2013; 
Ministerio de Salud, 2013) are inconvenient, costly, and 
uncomfortable because a patient is required to go to 
a hospital or clinic for an endoscopic gastric biopsy. Of 
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A b s t r a c t
The aim of this study was to develop a non-invasive diagnostic test for the detection of Helicobacter pylori in stool samples from digestive 
symptomatic patients, using a new protocol of nested-qPCR. A total of 143 patients were invited to participate in the study. A gastric biopsy 
of each patient was collected for Rapid Urease Testing (RUT) and histology by Giemsa stain. A fecal sample for nested-qPCR analysis was 
also obtained. DNA was extracted from the fecal samples, and conventional PCR followed by qPCR of the ureC gene of H. pylori was carried 
out. We evaluated the presence of H. pylori, in 103 females and 40 males, mean (± SD) age of 56.5 ± 14.18. The sensitivity of RUT to detect 
the infection was 67.0% (95% C.I.: 57.2 – 75.8) and specificity was 92.3% (95% C.I.: 76.5 – 99.1). Histology by Giemsa stain, commonly used 
as a reference for H. pylori detection, showed a sensitivity of 98.6% (95% C.I.: 92.5 – 100.0) and a specificity of 89.7% (95% C.I.: 72.7 – 97.8). 
In contrast, detection of H. pylori infection in stools by nested-qPCR showed a sensitivity of 100% (95% C.I.: 94.9 – 100.0) and a specificity 
of 83.9% (95% C.I.: 66.3 – 94.6). Our test, based in nested-qPCR is a better diagnostic alternative than conventional RUT, and is similar 
to histology by Giemsa stain in the detection of H. pylori, by which the test could be used for non-invasive diagnosis in clinical practice.
K e y  w o r d s: Helicobacter pylori, molecular diagnostics, nested-qPCR, stools
Taborda M.I. et al. 112
the non-invasive tests, the Urea Breath Test (C13-UBT) 
and the fecal antigen analysis stand out as the most 
valuable (Tamadon et al., 2013). C13-UBT is a fast and 
simple method that detects the presence of H. pylori 
in the gastric mucosa through urease activity of the 
pathogen (Di Rienzo et al., 2013). Moreover, the test 
shows high sensitivity and specificity, with sensitivity 
between 81–100%, and specificity between 80–98% 
(Honar et al., 2016), but the high initial investment of 
a isotope ratio mass spectrometer for obtaining results 
from C13-UBT is not feasible in most public health 
centers in developing countries. Furthermore, the use 
of anti secretory drugs or antibiotics can influence the 
results of the test (Di Rienzo et al., 2013).
Tests that detect H. pylori antigens in stool samples 
show high levels of specificity and sensitivity, similar to 
those for UBT (Dore et al., 2016), and lately the costs 
have become more practical for the population. How-
ever, the accuracy of these tests decreases when the 
stools are aqueous because H. pylori antigens become 
diluted. These methods are also not recommended for 
patients with gastric ulcers (Shimoyama, 2013).
In this context, the aim of the present study was to 
show and evaluate the efficacy of a new non-invasive 
diagnostic method based on nested-qPCR, using ureC 
as a gene marker to detect H. pylori in stools samples, 
even in patients with gastric ulcers or watery stools.
Experimental
Materials and Methods
Patients. For this study 143 patients with digestive 
symptoms were considered: 103 females and 40 males, 
who were attended to by the Hospital San Pablo, 
Coquimbo, Chile for a routine gastrointestinal endos-
copy. The mean (±SD) age of our patients was 56.5 years 
(± 14.18). The inclusion criteria of the patients were as 
follows: adults over 18 years old, with digestive symp-
tomatology, who had been tested for RUT and histo-
logy with Giemsa stain. The Bioethical Committee of 
the Health Service of Coquimbo, Chile, approved the 
protocol and patients voluntarily signed their consent.
A patent was requested for this protocol, with the 
N° 2016–01214 in INAPI (National Institute of Indus-
trial Property, Chile).
Endoscopy and biopsy samples. The endoscopic 
procedure was performed in Hospital San Pablo, 
Coquimbo, Chile. Gastric biopsy samples were obtained 
from each patient for RUT and histology by Giemsa 
stain analyses, which were processed in the Service 
of Pathological Anatomy of the Hospital San Pablo 
according to standard protocols. The same pathologist 
performed the analysis of all biopsy samples.
Stool samples. Stools by normal evacuation were 
obtained from each patient before the endoscopic pro-
cedure. Each patient provided ~ 5 g of stools placed in 
a flask containing 3 ml of RNA Later® (Ambion), which 
were stored in a deep freezer (–80°C) until analysis.
DNA purification and PCR amplification. Appro-
ximately 200 mg of each stool sample was used to extract 
DNA, using QIAamp® Fast DNA Stool Mini Kit (QIA-
GEN) according to the manufacturer’s protocol. Later, 
120 ng of the extracted DNA was used to amplify the 
H. pylori ureC gene by nested-qPCR. DNA concen-
tration was quantified by NanoDropTM One (Thermo 
ScientificTM). In brief, a first amplification with con-
ventional PCR was performed in a Axygen® MaxyGene 
Thermal Cycler II, incubating 120 ng of DNA with 5 μl 
Buffer 5x; 1.5 μl MgCl2 25 mM; 0.5 μl dNTPs 10 mM; 
1 μl of each external primer (10 μM each), and 0.2 µl of 
Platinum Taq® DNA polymerase (5U/μl) (Invitrogen), in 
a final volume of 25 μl. Amplification conditions were as 
follows: a pre-denaturation of 95°C for 5 min, 25 cycles 
of 95°C for 45 s, 57°C for 45 s and 72°C for 45 s, followed 
by a final extension at 72°C for 10 min. Posteriorly, 2 µl 
of a 10 × dilution of this first PCR were used for sub-
sequent amplification by qPCR in an Eco Real Time 
PCR (Illumina®). The qPCR mix contained 5 µl of SYBR 
Green kit 2x (KAPA SYBR® FAST qPCR) and 0.1 µl of 
each internal primer (10 µM each), in a final volume of 
10 µl. Amplification conditions were: pre-denaturation 
at 95°C for 5 min, and 30 cycles of 95°C for 10 s and 
60°C for 30 s. Sequences of primers are shown in Table I.
Data analysis. Data was analyzed using the Software 
Eco v4.1 PCR System and the program XLSTAT Ver-
sion 2.06 to calculate sensitivity, specificity, and positive 
and negative ratio probability for each of the three tech-
niques: nested-qPCR, RUT and histology by Giemsa 
stain for detection of H. pylori infection in sympto- 
matic digestive patients. Cases for each technique were 
considered to be H. pylori infected according to a com-
External primers ureC FExt: 5’-AGCTATAAAGTGGGCGAGAG-3’ 224 bp RExt: 5’-ATTGCACCCGTTAGGCTCAT-3’
Internal primers ureC FInt: 5’- GCGTTGGCAGTGCTAAAAGG-3’ 127 bp RInt: 5’-AGCCGTATCTAACACGATCC-3’
Table I
Primers used for qPCR assay.
Sequence (5’-3’) of primers Amplicon size
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bined gold standard of RUT/histology, RUT/qPCR 
or histo logy/qPCR, as applicable. P values < 0.05 were 
considered significant.
Results
A total of 143 patients with digestive symptoms were 
evaluated by endoscopy, and the presence of H. pylori 
was evaluated by a novel method of nested-qPCR, and 
corroborated with RUT and histology by Giemsa stain. 
We use a combined gold standard for each test evalu-
ated. A patient was considered positive or negative for 
H. pylori when both of tests used as gold standard gave 
the same result for the infection. Results of the three 
tests are shown in Table II.
RUT, the standard method used in medical practice 
to detect the presence of this bacterium, only detected 
infection in 71/134 patients (53.0%), with a  sensiti-
vity of 67.0% (95% C.I.: 57.2 to 75.8) and a specific-
ity of 92.3% (95% C.I.: 76.5% to 99.1); in turn, PPV 
was 97.3% (95% C.I.: 90.3 to 99.3) and NPV was 42.6% 
(95% C.I.: 35.7 to 49.8).
Male High antral lesion benign appearance + + +
Female Congestive and petechial gastropathy. Duodenal diverticulum – + +
Female Congestive gastropathy – – +
Male Petechial gastropathy, hiatal hernia  – + +
Male Gastric ulcer, esophagitis b group, hiatal hernia  + + +
Female Erosive gastropathy, erosive duodenitis, grade I esophagitis + + +
Male Barrett esophagus esophageal ulcer antral raised lesions + + +
Male Normal, hiatal hernia  – + +
Female Normal – + +
Female Erosive gastropathy + + +
Female Congestive gastropathy – + +
Female Erosive gastropathy – Esophagitis group b of los angeles + + +
Male Normal – + +
Female Congestive gastropathy – Eosinophilic Esophagitis + + +
Male Normal – – +
Male Normal – + +
Female Erosive gastropathy antral multiple polyps fundus – + +
Female Obs. Celiac Disease – + +
Male Normal – – –
Male Antral erosive gastropathy – + –
Female Erosive Gastropathy – + +
Female Normal – – –
Female Normal + + +
Female Normal + + +
Female Normal – + +
Female Hiatal hernia, duodenopathy and congestive gastropathy + + +
Female Hiatal hernia, duodenopathy and congestive gastropathy + + +
Female Normal + + +
Male Hiatal hernia, duodenopathy and congestive gastropathy + + +
Female Without anormal findings + + +
Female Normal + + +
Male Normal – + +
Female Duodenal ulcer scar (Ulcerous Bulb) – + +
Female High Antral Lesion + + +
Male Petechial gastropathy + + +
Female Normal + + +
Female Hiatal hernia, erosive esophagitis servera, grade d of los angeles – – –
Table II
Results of RUT, Histology and Real Time-PCR, for detect H. pylori in patients.
Gender Diagnostic RUT Histology qPCR UreC
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Female Normal – + +
Female Congestive gastropathy + + +
Male Congestive Duodenitis, Antral Erosive Gastritis + + +
Female Normal – – –
Female Ulcerous Bulb – + +
Female Antral Congestive Gastropathy, Nodular + + +
Female Antral Erosive Gastropathy, High Antral Lesion, Benign aspect + + +
Male Esophagitis Grade 1 + + +
Female Chronic active gastritis, no evidence of malignant neoplasm is recognized + + +
Male Esophageal Candidiasis + + +
Female Congestive gastropathy + + +
Female Normal + + +
Female Atrophic Chronic Gastropathy – + +
Female Esophagitis Grade 1, Chronic Atrophic Gastritis – + +
Female Petechial gastropathy, Erosive Gastropathy. + + +
Female Gastritis Congestiva – + +
Male Normal + + +
Male Barrett’s esophagus, antral ulcer on the anterior aspect of the minor curve – + +
Female Esophageal submucous lesion – – –
Female Gatritis congestive – – –
Female Normal + – –
Female Normal + + +
Female Normal + + +
Female Congestive and deformed bulb, micronodular gastropathy + + +
Female High Endoscopy Normal + – +
Male Endoscopy High Normal; Chronic non-specific gastritis – + +
Female Endoscopy High Normal; Chronic non-specific gastritis – + +
Female Gastropathy; Moderate non-specific esophagitis, Chronic atrophic gastritis – + +
Female Chronic gastritis with intestinal metaplasia, suggestive but not conclusive finding of Carcinoma + + +
Female Possible Congestive and Atrophic Arthropathy, Erosive Duodenopathy;
 Chronic atrophic gastritis with intestinal metaplasia and indeterminate atypia – + +
Male Congestive Gastropathy; Chronic Non-Specific Gastritis – + +
Male Polyps; Chronic Non-specific Gastritis, Tubular adenoma with moderate epithelial dysplasia + + +
Male Chronic gastropathy, hiatal hernia Esophagitis Moderate to severe erosion;
 Chronic atrophic gastritis with intestinal metaplasia. – – –
Male Antral Intestinal Metaplasia; Chronic atrophic gastritis with intestinal metaplasia,
 Chronic non-specific gastritis – + +
Female Control Antral Intestinal Metaplasia with important Regression;
 Chronic gastritis with intestinal metaplasia + + +
Male Chronic non-specific gastritis – – –
Female Congestive Duodenopathy; Chronic non-specific gastritis – + +
Male Moderate to severe erosive esophagitis, gastric ulcers; Chronic atrophic active gastritis,
 Intense esophagitis, Esophageal candidiasis – – –
Female Mild erosive esophagitis, erosive gastropathy and congestive duodenitis,
 increased duodenal papilla volume; Chronic active gastritis + + +
Male Erosive gastropathy, Antral intestinal metaplasia, Chronic gastritis with focal
 intestinal metaplasia – – –
Male Congestive and erosive gastropathy. Possible proliferative lesion
 (lymphoma or adenocarcinoma). Chronic active gastritis with intestinal metaplasia + + +
Male Intense gastropathy; Chronic gastritis with intestinal metaplasia and moderate dysplasia + + +
Table II. Continued
Gender Diagnostic RUT Histo-logy
qPCR
UreC
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Male Antral intestinal metaplasia, gastric xanthoma, chronic gastritis with intestinal metaplasia – + +
Female Congestive and petechial gastropathy, sessile polyps; Chronic non-specific gastritis, 
 hyperplastic type polyps – – –
Male Polyps; Chronic gastritis with intestinal metaplasia – + +
Female Chronic gastritis – – +
Female Mild erosive esophagitis; Fibrous polyps; Chronic gastritis with mild atrophy,
 mild intestinal metaplasia – – –
Female Active chronic gastritis with focal intestinal metaplasia – + +
Female Chronic atrophic gastropathy with intestinal metaplasia; Active chronic and atrophic gastritis + + +
Female Petechial gastropathy, Gastric scars; Active chronic gastritis + + +
Male Chronic non-specific gastritis – – –
Female Atrophic gastropathy, Gastric polyps Yamada I; Chronic gastritis – – +
Female Petechial gastropathy, antral erosions; Chronic gastritis + + +
Male Esophagitis Grade I; Chronic gastritis – – –
Male Hiatal hernia, antral congestive gastropathy, esophageal candidiasis;
 Chronic non-specific gastritis – + –
Female Gastric ulcer, Active chronic gastropathy with intestinal metaplasia + + +
Female Mild esophageal stricture; Chronic Gastritis with Intestinal Metaplasia + + +
Female Normal; Chronic gastritis – – –
Male Normal; Chronic gastritis Active mild with moderate atrophy – + –
Female Chronic gastropathy – + +
Female Chronic gastritis with moderate atrophy and extensive metaplasia, Chronic Active Gastritis
 with mild Intestinal metaplasia + + +
Female Gastric Polyps; Mild Chronic Gastritis with Moderate Atrophy and Focal Intestinal
 Metaplasia, Chronic Active Gastritis with Foveolar Hyperplasia + + +
Female Chronic gastropathy; Chronic mild gastritis – – –
Male Grade I esophagitis, chronic gastropathy, erosive duodenitis; Chronic non-specific
 active gastritis + – –
Male Chronic atrophic gastritis with mild intestinal metaplasia, moderately differentiated
 tubular adenocarcinoma – – –
Female Esophagitis type A of los angeles; Active Chronic Gastritis with mild atrophy,
 Active Chronic Gastritis with mild atrophy and focal intestinal metaplasia 
+ + +
Female Atrophic gastropathy; Mild chronic gastritis with mild atrophy – – +
Female Antral Chronic Gastritis; Active Chronic Gastritis with mild atrophy and mild
 intestinal metaplasia + + +
Female Antral atrophic gastropathy, Hiatal hernia, Chronic gastritis with mild atrophy, 
 on-specific chronic gastritis – – –
Female Ulcerous bulb; Mild chronic gastritis with mild atrophy – – –
Female Antral superficial gastropathy; Moderate atrophy and intestinal metaplasia,
 Chronic gastritis with mild inflammatory activity and mild atrophy + + +
Female Chronic gastropathy; Moderate chronic gastritis, Non-specific chronic gastritis, 
 mild chronic gastritis + + +
Female Chronic gastropathy; Chronic gastritis with mild inflammatory activity,
 moderate intestinal metaplasia – – –
Female Nodular Gastropathy; Chronic active gastritis with moderate inflammatory activity
 and moderate atrophy. + + +
Male Antral Erosive Gastropathy; Moderate chronic gastritis with mild atrophy and focal 
 metaplasia; Moderate atrophy and focal intestinal metaplasia 
+ + +
Female Antral atrophic gastropathy; Moderate chronic gastritis with mild atrophy and moderate
 intestinal metaplasia + + +
Female Hiatal Hernia; Mild chronic gastritis, Chronic gastritis with mild inflammatory activity
 and mild atrophy + + +
Table II. Continued
Gender Diagnostic RUT Histo-logy
qPCR
UreC
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Histology with Giemsa stain classified 71/101 patients 
(70.3%) as H. pylori positive. Between these patients, 
92 had a histologic diagnosis associated with gastroin-
testinal disease, and the remaining 9 tested normal for 
histology. Sensitivity for this test was 98.6% (95% C.I.: 
92.5 to 100.0) and specificity 89.7% (95% C.I.: 72.7 to 
97.8); PPV was 96.0% (95% C.I.: 89.0 to 98.6) and NPV 
was 96.3% (95% C.I.: 78.7 to 99.5).
Using a nested-qPCR approach, we identified infec-
tion of H. pylori in 71/102 patients (69.6%), with a sen-
sitivity to detect the presence of the bacterium in stools 
of 100% (95% C.I.: 94.9–100.0), and specificity of 83.9% 
(95% C.I.: 66.3 to 94.6); Finally, PPV and NPV were 
93.4% (95% C.I.: 86.4 to 96.9) and 100.0% (95% C.I.: 
84.0–100.0), respectively. A 2.5% agarose gel electropho-
resis stained with ethidium bromide with the amplifica-
tion of five positive samples for H. pylori is showed in 
Figure 1. Complete results are shown in Tables III–V. 
Comparative results between sensitivity, specificity, PPV 
and NPV for each test are shown in Table VI.
Table II. Continued
Gender Diagnostic RUT Histo-logy
qPCR
UreC
Female Antral erosive gastropathy; Chronic gastritis with moderate inflammatory activity,
 mild intestinal metaplasia and mild atrophy + + +
Female Chronic atrophic lithiasis gastropathy; Mild chronic gastritis with mild atrophy,
 Chronic gastritis with moderate atrophy and extensive intestinal metaplasia – – –
Female Atrophic corpora-antral gastropathy; Active chronic gastritis with moderate atrophy + + +
Female Esophagitis type C Los angeles, Hiatal Hernia, Non-specific chronic gastritis – – –
Female Chronic gastritis with mild atrophy and focal intestinal metaplasia – + +
Female Chronic non-specific gastritis – + +
Female Nodular gastropathy; Chronic non-specific gastritis, Chronic gastritis with mild atrophy – – –
Male Chronic gastropathy; Chronic gastritis with mild activity, mild atrophy
 and focal intestinal metaplasia + + +
Female Hiatal Hernia; Chronic non-specific gastritis – – –
Female Petechial gastropathy; Active chronic gastritis with moderate atrophy + + +
Female Erosive Duodenitis, Duodenal ulcer scar; Chronic non-specific gastritis, 
 Hyperplastic type polyps + + +
Female Duodenal polyps; Chronic non-specific gastritis – + +
Female Hiatal hernia, antral gastropathy, chronic gastritis with focal intestinal metaplasia – – –
Female Antral atrophic gastropathy, antral erosive gastropathy; Chronic non-specific gastritis,
 mild chronic gastritis – + +
Female Chronic gastritis with mild atrophy and mild intestinal metaplasia – + +
Female Petechial Gastropathy, Non-specific chronic gastritis + + +
Female Chronic gastropathy; Mild non-specific chronic gastritis + + +
Female Active chronic gastritis with moderate atrophy and moderate intestinal metaplasia;
 Chronic active gastritis with mild atrophy + + +
Female Nodular Gastropathy; Chronic active gastritis, chronic non-specific gastritis + + +
Male Antral superficial gastropathy; Chronic non-specific gastritis + + +
Female Intestinal metaplasia; Chronic gastritis with mild atrophy
 and mild intestinal metaplasia + + +
Female Antral Nodular Gastropathy; Active chronic gastritis with mild atrophy, 
 Non-specific chronic gastritis + + +
Female Erosive duodenitis, antral superficial gastropathy; Active chronic gastritis
 with moderate atrophy + + +
Female Esophagitis type A Los Angeles, erosive gastropathy antral; Active chronic gastritis
 with mild atrophy + + +
Female Erosive gastropathy; Mild non-specific chronic gastritis + + +
Female Normal; Chronic non-specific gastritis – – –
Female Chronic gastropathy; Chronic active gastropathy with mild atrophy + + +
Female Chronic gastropathy; Chronic non-specific gastritis + + +
Male Chronic gastritis with mild atrophy and mild intestinal metaplasia + + +
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Discussion
In this work, we evaluated a combined method of 
nested-qPCR for detection of infection by H. pylori 
in the stools of 143 gastrointestinal symptomatic 
patients, and demonstrated that this technique is supe-
rior to RUT, the invasive test commonly used in clinical 
practice today.
One of the pioneering works in this area was con-
ducted in 1994, in which stools of 24 patients diag-
nosed with H. pylori infection were analyzed by PCR. 
Half of the patients had gastric ulcers at the time of 
endoscopy, while the other 12 had only related dys-
pepsia. Unfortunately, this study was unable to show 
that PCR technique is helpful to diagnose infection by 
the pathogen in the stools. Nonetheless, by inoculating 
each of the samples with 103 bacteria/mg of feces they 
received a  positive result for all samples, a successful 
advancement in this technique (Mishra et al., 2008). In 
1998, a  new protocol to detect H. pylori by PCR was 
tested on 100 patients (63 diagnosed with H. pylori and 
37 healthy for the pathogen). This technique identified 
59 infected patients (sensitivity 93.7%), while all unin-
fected patients tested negative by PCR (specificity 100%) 
(Aktepe et al., 2011). Moving forward, several studies 
have shown that this technique may be a useful clinical 
alternative for H. pylori detection in stool samples. In 
this regard, a study from India in 2008 used nested-PCR 
of feces to demonstrate the prevalence of infection in the 
population of that country, finding that of 245 patients 
evaluated 105 were detected as positive for infection, 
using a new model for clinical evaluation (Momtaz et al., 
2012). Alas, this study did not corroborate their findings 
with currently accepted techniques, such as RUT or his-
tology. However, this same group later showed that this 
technique has a high sensitivity, finding 40/52 patients 
positive for H. pylori according by RUT and biopsy, with 
a sensitivity of 72.5% (Smith et al., 2012).
Another study applied the stool PCR test to 
300 patients, 271 of them positive for H. pylori by RUT, 
finding 167/300 positive by PCR (61.6%), using the 
ureC gene as a marker (Uno et al., 2016). Liu and cow-
orkers (2016) evaluated stool samples of 97 digestive 
symptomatic patients by PCR, with the ureC marker 
and compared their results with UBT. In this work, sen-
sitivity was 42.6% and specificity was 100% (Liu et al., 
2016). The authors claim that despite the observed low 
sensitivity, this technique could be useful for diagnosis 
in children, especially in health centers that do not have 
pediatric endoscopes.
In 2014 Patel et al. presented a review suggesting 
that PCR could be superior to other diagnostic tests 
for detection of H. pylori infection, owing to higher 
sensitivity and specificity, especially with nested and 
semi-nested approaches (Patel et al., 2014).
In this work, we found that our nested-qPCR is 
more effective than RUT and similar to histology by 
RUT + 71  2
RUT – 35 26
Table III
Results of RUT vs Histology/qPCR.
p < 0.0001
Disease Positive Disease Negative
Histology + 71  3
Histology –  1 26
Table IV
Results of histology-Giemsa vs RUT/qPCR.
p < 0.0001
Disease Positive Disease Negative
qPCR + 71  5
qPCR –  0 26
Table V
Results of qPCR vs RUT/histology.
p < 0.0001
Disease Positive Disease Negative Sensitivity (%) 67.0% 98.6% 100%
Specificity (%) 92.9% 89.7% 83.9%
PPV (%) 97.3% 96.0% 93.4%
NPV (%) 42.6% 96.3% 100%
Table VI
Comparative evaluation of RUT, histology and nested qPCR
for detection of H. pylori.
Parameter RUT Histology qPCR
Fig. 1. 2.5% agarose gel electrophoresis stained with ethidium 
bromide, showing the amplification of five fecal samples positives 
for H. pylori.
C–: Negative control; C+: Positive control (H. pylori strain 26695); MW: 
Molecular weight 100 bp.
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Giemsa stain in detecting the presence of infection by 
H. pylori in the patients with digestive symptoms, with 
a sensitivity of 100% and a specificity of 83.9%. PPV 
and NPV values were 93.4% (95% C.I.: 86.4 to 96.9) and 
100.0% (95% C.I.: 84.0–100.0), respectively.
It is important to note that specificity is close to 
84%, as our technique detected five fecal samples as 
positive for H. pylori, which were not detected by RUT 
or histology. We repeated the test on the samples in 
question three more times with different portions of the 
fecal samples, and in all of them the result was positive 
for H. pylori. We hypothesized that our technique had 
the potential to detect the presence of small quantities 
of nucleotides from H. pylori beyond the limit of detec-
tion of the compared techniques.
Moreover, the nested-qPCR method is non-invasive 
and the patient needs only to send a stool sample to the 
laboratory, eliminating the need to go to the hospital. 
Currently RUT, with its low sensitivity, is the stand-
ard test in the medical practice. Indeed, in our patients 
the sensitivity of RUT was only of 67.0%, a result likely 
associated with ulcer bleeding or the use of proton 
pump inhibitors, which can give RUT a false negative 
(Coelho and Coelho, 2014). This is not an issue for PCR 
based diagnostics. 
The proposal that blood could affect the sensitivity 
of RUT, by the presence of albumin acting as a buffer 
on the pH indicator of the reaction, is controversial, 
because other studies report that blood has no effect 
on the test (Honar et al., 2016). 
Our results are encouraging because this technique 
could soon become a non-invasive method for detec-
tion of H. pylori in stools, providing the population with 
an inexpensive and sensitive method to observe pres-
ence of the bacterium. 
We are waiting for the approval of our patent request 
Nº 2016-01214 for this protocol in INAPI.
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